June 21, 2020Open Access

Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Serial ctDNA analysis may offer clinically useful predictive and prognostic markers for response to preoperative therapy and postoperative recurrence in patients with LARC.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Murahashi et al. (Sun,) studied this question.

synapsesocial.com/papers/69dd39680a7b4bc8c4100fe1 https://doi.org/https://doi.org/10.1038/s41416-020-0941-4

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing2017 · 32 citations
2Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer1997 · 2,520 citations
3Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions2014 · 30 citations
4Cancer DNA in the Circulation2017 · 94 citations
5Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer2015 · 76 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo